Article Information
History
- April 29, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 29, 2021 - 21:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Institute of Health System Engineering, College of Engineering, Peking University, Beijing, China, 100871
- 2Department of Chemistry, Princeton University, Princeton, NJ, 08540
- 3State Key Laboratory for Turbulence and Complex Systems, Peking University, Beijing, China, 100871
- 4Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China, 100730
- ↵*Corresponding author: Gregory D. Scholes, 609-258-0729, gscholes{at}princeton.edu, 125, Frick Laboratory, Department of Chemistry, Princeton University, Princeton, NJ, and Zhen-Su She, 010-62766559, she{at}pku.edu.cn, 206, Peking University State Key Laboratory of Turbulence and Complex Systems, Beijing, China.
↵† These authors contribute equally
Author Contributions: L.Z., G.S. and R.L. performed research; Z.S. and R.L. designed research; L.Z, R.L., Z.S., G.S., G.D.S. wrote the paper; Z.S. supervised the project; G.D.S funded the project
Posted April 29, 2021.
Impairment of T cells’ antiviral and anti-inflammation immunities dominates the death from COVID-19
